Evidence map›Paper›PMID 32417404›Full record

ReviewGastroenterology2020

Use of Single-Cell -Omic Technologies to Study the Gastrointestinal Tract and Diseases, From Single Cell Identities to Patient Features.

Mirazul Islam, Bob Chen, Jeffrey M Spraggins, Ryan T Kelly, Ken S Lau

Open access · bronzeAbstract readReview
In one paragraph

Review in Gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Long Noncoding RNANon-coding RNA · 2026
    Article
  3. Article
  4. Article
  5. Metabolomics reveals soluble epoxide hydrolase as a therapeutic target for high-sucrose diet-mediated gut barrier dysfunction.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Omics and Multi-Omics in IBD: No Integration, No Breakthroughs.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Review
  10. Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection.Journal of neural transmission (Vienna, Austria : 1996) · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mirazul IslamEpithelial Biology Center and Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Bob ChenChemical and Physical Biology Program, Vanderbilt University, Nashville, Tennessee.
Jeffrey M SpragginsMass Spectrometry Research Center, Departments of Biochemistry and Chemistry, Vanderbilt University, Nashville, Tennessee.
Ryan T KellyDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, Utah.
Ken S LauEpithelial Biology Center and Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; Chemical and Physical Biology Program, Vanderbilt University, Nashville, Tennessee. Electronic address: ken.s.lau@vanderbilt.edu.
Vanderbilt University · USBrigham Young University · US

Funding

Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2019 to 2026
$19.6M
Molecular, Cellular and Tissue Characterization UnitU2CCA233291 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2018 to 2023
$12.2M
Vanderbilt University Biomolecular Multimodal Imaging Center for 3-Dimensional Tissue MappingU54DK120058 · NIDDK · VANDERBILT UNIVERSITY · PI HARRIS, RAYMOND C. · 2018 to 2021
$5.7M
Tuft cell heterogeneity in function, lineage, and structure in ileal inflammatory diseaseR01DK103831 · NIDDK · VANDERBILT UNIVERSITY · PI LAU, KEN S · 2016 to 2024
$4.4M
Area A: In-Depth Proteome Mapping of the Tumor Microenvironment with Single-Cell ResolutionR33CA225248 · NCI · BRIGHAM YOUNG UNIVERSITY · PI KELLY, RYAN T · 2017 to 2017
$1.7M
BIDS: Vanderbilt Training Program in BIg Biomedical Data ScienceT32LM012412 · NLM · VANDERBILT UNIVERSITY · PI BLUME, JEFFREY D., GADD, CYNTHIA S · 2016 to 2020
$1.5M
NCI NIH HHS P50 CA236733NCI NIH HHS R33 CA225248NCI NIH HHS U2C CA233291NIDDK NIH HHS R01 DK103831NIDDK NIH HHS U54 DK120058NLM NIH HHS T32 LM012412
6 · The paper itself

Abstract

Single cells are the building blocks of tissue systems that determine organ phenotypes, behaviors, and functions. Understanding the differences between cell types and their activities might provide us with insights into normal tissue physiology, development of disease, and new therapeutic strategies. Although -omic level single-cell technologies are a relatively recent development that have been used only in research settings, these approaches might eventually be used in the clinic. We review the prospects of applying single-cell genome, transcriptome, epigenome, proteome, and metabolome analyses to gastroenterology and hepatology research. Combining data from multi-omic platforms coupled to rapid technological development could lead to new diagnostic, prognostic, and therapeutic approaches.

Indexed as

Single-Cell AnalysisBiomedical ResearchGastrointestinal DiseasesGastrointestinal TractGene Expression ProfilingGenomicsHumansMetabolomicsProteomicsEpigenomicsHeterogeneityMetabolomicsProteomicsTranscriptomics

Identifiers

PMID32417404
PMCPMC7484006
OpenAlexW3024506599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.